Psychedelic Therapy Groups Formed New Partnership
The Multidisciplinary Association for Psychedelic Studies joined forces with the International Alliance of Psychedelic Therapy Practitioners.
Updated on Oct. 5, 2026 in Mental Health
Live Poll
Do you believe professional partnerships between non-profits help ensure higher ethical standards in emerging medical fields?
The Multidisciplinary Association for Psychedelic Studies (MAPS) has partnered with the International Alliance of Psychedelic Therapy Practitioners to standardize psychedelic-assisted therapy. This collaboration aims to formalize clinical training and professional education programs.
Why it matters
The collaboration intends to build the professional infrastructure required for the sustainable development of psychedelic-assisted therapy. By combining expertise, the organizations hope to establish consistent clinical standards for practitioners.
Since its founding in 1986, MAPS has received over $150 million in philanthropic funding. The extent of practitioner access under the new scholarship and sponsored-attendance programs remains to be determined.
The players
Multidisciplinary Association for Psychedelic Studies
This is a nonprofit research and educational organization that has operated since 1986.
International Alliance of Psychedelic Therapy Practitioners
This professional association was formed in 2023 to support those working in the field of psychedelic-assisted therapy.
The details
The partnership focuses on training, clinical consultation, and continuing education to improve the professional standards of the field. The organizations will utilize existing MAPS scholarship and sponsored-attendance programs to broaden practitioner access.
Timeline
MAPS was founded in 1986.
The International Alliance of Psychedelic Therapy Practitioners formed in 2023.
The International Alliance of Psychedelic Therapy Practitioners begins accepting new members in October 2026.
Health Landscape
This partnership marks a significant institutional expansion of the professional framework established by the 1986 founding of the Multidisciplinary Association for Psychedelic Studies. It signals a move toward rigorous clinical standardization within the emerging sector of psychedelic-assisted therapy.
Patients seeking psychedelic-assisted therapy may benefit from more standardized treatment protocols and better-trained practitioners as these organizations align their clinical guidelines. The training initiative aims to increase the number of qualified professionals available to offer these therapies.
The takeaway
This collaboration highlights a broader push to move psychedelic medicine toward mainstream clinical acceptance through professional regulation. Practitioners and interested stakeholders should monitor the new membership requirements coming in 2026 to stay informed on credentialing changes.
What happens next
The International Alliance of Psychedelic Therapy Practitioners will officially begin accepting new members starting in October 2026.
Further reading
For additional context on the evolution of care, visit the Mental Health section.
Live Poll
Do you believe professional partnerships between non-profits help ensure higher ethical standards in emerging medical fields?
